Abstract
ObjectiveOur study examines how non-small cell lung cancer (NSCLC) survivors undergoing immunotherapy can experience reduced anxiety and psychological distress, improved quality of life (QOL) and increased immunotherapy efficacy.Methods133 men and...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have